ReviewWorld journal of urology2026
Implantable tibial neuromodulation with an Anklet for overactive bladder: a review.
Review in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOveractive bladder (OAB) is a prevalent chronic condition associated with substantial impairment in quality of life (QoL). Although conservative and pharmacological therapies remain first- and second-line treatment options, long-term adherence and efficacy are often limited by variable treatment response. Implantable tibial neuromodulation (iTNM) using an external wearable ankle stimulator has emerged as a minimally invasive therapeutic strategy combining the durability of implantable neuromodulation with the convenience of wireless home-based therapy. This review provides an overview of currently investigated iTNM systems incorporating an external wearable stimulator anklet for the treatment of OAB.
methodsA narrative review of the literature was performed on iTNM systems using an external anklet stimulator. Studies evaluating clinical efficiacy, safety, durability, device characteristics and patient-centered outcomes were reviewed.
results14 studies were included. Three iTNM systems incorporating an external external anklet stimulator were identified: the Urgent-SQ, Protect PNS, and the Revi system (formerly RENOVA iStim). Clinically meaningful improvements were observed in urgency symptoms, urinary frequency, urge urinary incontinence (UUI) episodes, and quality of life (QoL). Safety outcomes were generally favorable, with adverse events (AEs) predominantly mild and transient. Implant migration or dislocation, revision procedures, and device-related serious adverse events (SAE) were infrequently reported.
conclusionCurrent evidence suggests that iTNM using an external anklet stimulator may provide an effective and minimally invasive treatment option for patients with refractory OAB and UUI, with encouraging safety and durability outcomes. Although further comparative and long-term studies are warranted, iTNM appears to be an relevant addition to the third-line OAB management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.